BioCentury
ARTICLE | Finance

Akouos’ first-day pop outshines peers among NASDAQ IPO trio

Fusion, PolyPid join the gene therapy company on NASDAQ, Hyloris prices IPO on Euronext

June 26, 2020 9:19 PM UTC

Among a trio of companies making their NASDAQ debuts on Friday, Akouos’ first-day rise of 29% was the biggest, while Fusion gave back its early gains and PolyPid also climbed in the aftermarket.

Across the Atlantic, Belgian drug reformulation company Hyloris Pharmaceuticals S.A. (Euronext:HYL) raised €62 million ($69 million) in an IPO on Euronext Brussels...